Literature DB >> 29658059

Visceral fat area, not body mass index, predicts postoperative 30-day morbidity in patients undergoing colon resection for cancer.

Benjamin A Kuritzkes1, Emmanouil P Pappou2, Ravi P Kiran3,4, Onur Baser4, Liqiong Fan4, Xiaotao Guo5, Binsheng Zhao5, Stuart Bentley-Hibbert6.   

Abstract

PURPOSE: Colectomy for cancer in obese patients is technically challenging and may be associated with worse outcomes. Whether visceral obesity, as measured on computed tomography, is a better predictor of complication than body mass index (BMI) or determines long-term oncologic outcomes has not been well characterized. This study examines the association between derived anthropometrics and postoperative complication and long-term oncologic outcomes.
METHODS: Retrospective review of patients undergoing elective colectomy for cancer at a single tertiary-care center from 2010 to 2016. Adipose tissue distribution measurements, including visceral fat area (VFA), were determined from preoperative imaging. The primary outcome was 30-day postoperative complication; secondary outcomes included overall and disease-free survival. Multivariable logistic regression was performed to determine association between obesity metrics and outcome.
RESULTS: Two hundred and sixty-four patients underwent 266 primary resections of colon cancer. Twenty-eight patients (10.5%) developed major morbidity (Clavien-Dindo grade ≥ III). VFA but not BMI was significantly associated with morbidity in multivariate analysis (p = 0.004, odds ratio 1.99, 95% confidence interval 1.25-3.19). No other imaging-derived anthropometric was associated with increased morbidity. In receiver operating characteristic analysis, VFA was predictive of major morbidity (area under curve 0.660). A cutoff value of VFA ≥ 191 cm2 was associated with 50% sensitivity and 76% specificity for predicting major morbidity. Patients with VFA ≥ 191cm2 had 19.4% risk of morbidity, whereas those with < 191 cm2 had 7.2% risk (relative risk ratio 2.69, unadjusted p = 0.004). Neither VFA nor BMI was associated with overall or disease-free survival.
CONCLUSION: VFA but not BMI predicts morbidity following elective surgery for colon cancer.

Entities:  

Keywords:  Abdominal obesity; Clinical outcomes; Colon cancer; Visceral fat area; Visceral obesity

Mesh:

Year:  2018        PMID: 29658059      PMCID: PMC6198796          DOI: 10.1007/s00384-018-3038-2

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  40 in total

1.  Automated quantification of body fat distribution on volumetric computed tomography.

Authors:  Binsheng Zhao; Jane Colville; John Kalaigian; Sean Curran; Li Jiang; Peter Kijewski; Lawrence H Schwartz
Journal:  J Comput Assist Tomogr       Date:  2006 Sep-Oct       Impact factor: 1.826

2.  Measurement of visceral fat on preoperative computed tomography predicts complications after sigmoid colectomy for diverticular disease.

Authors:  Rafel Tappouni; Paul Mathew; Tara M Connelly; Franklyn Luke; Evangelos Messaris
Journal:  Am J Surg       Date:  2015-03-07       Impact factor: 2.565

3.  Impact of obesity on perioperative complications and long-term survival of patients with gastric cancer.

Authors:  Kai A Bickenbach; Brian Denton; Mithat Gonen; Murray F Brennan; Daniel G Coit; Vivian E Strong
Journal:  Ann Surg Oncol       Date:  2012-09-14       Impact factor: 5.344

Review 4.  Quantification of hepatic and visceral fat by CT and MR imaging: relevance to the obesity epidemic, metabolic syndrome and NAFLD.

Authors:  Peter M Graffy; Perry J Pickhardt
Journal:  Br J Radiol       Date:  2016-03-09       Impact factor: 3.039

5.  The obesity paradox, cardiorespiratory fitness, and coronary heart disease.

Authors:  Paul A McAuley; Enrique G Artero; Xuemei Sui; Duck-chul Lee; Timothy S Church; Carl J Lavie; Jonathan N Myers; Vanesa España-Romero; Steven N Blair
Journal:  Mayo Clin Proc       Date:  2012-04-12       Impact factor: 7.616

6.  Robot-assisted versus laparoscopic surgery for lower rectal cancer: the impact of visceral obesity on surgical outcomes.

Authors:  Akio Shiomi; Yusuke Kinugasa; Tomohiro Yamaguchi; Hiroyasu Kagawa; Yushi Yamakawa
Journal:  Int J Colorectal Dis       Date:  2016-09-06       Impact factor: 2.571

7.  Visceral adiposity and hepatic steatosis at abdominal CT: association with the metabolic syndrome.

Authors:  Perry J Pickhardt; Young Jee; Stacy D O'Connor; Alejandro Muñoz del Rio
Journal:  AJR Am J Roentgenol       Date:  2012-05       Impact factor: 3.959

8.  Effect of Visceral Obesity on Surgical Outcomes of Patients Undergoing Laparoscopic Colorectal Surgery.

Authors:  Byung Kwan Park; Ji Won Park; Seung-Bum Ryoo; Seung-Yong Jeong; Kyu Joo Park; Jae-Gahb Park
Journal:  World J Surg       Date:  2015-09       Impact factor: 3.352

9.  The impact of obesity on outcomes following pancreatectomy for malignancy.

Authors:  Matthew Benns; Charles Woodall; Charles Scoggins; Kelly McMasters; Robert Martin
Journal:  Ann Surg Oncol       Date:  2009-06-26       Impact factor: 5.344

10.  Distribution and Impact of the Visceral Fat Area in Patients With Colorectal Cancer.

Authors:  Hyeon Yu; Yong-Geul Joh; Gyung-Mo Son; Hyun-Sung Kim; Hong-Jae Jo; Hae-Young Kim
Journal:  Ann Coloproctol       Date:  2016-02-29
View more
  8 in total

1.  The effect of increased body mass index values on surgical outcomes after radical resection for low rectal cancer.

Authors:  Xubing Zhang; Qingbin Wu; Chaoyang Gu; Tao Hu; Liang Bi; Ziqiang Wang
Journal:  Surg Today       Date:  2019-02-18       Impact factor: 2.549

2.  The Effectiveness of Contralateral Drainage in Reducing Superficial Incisional Surgical Site Infection in Loop Ileostomy Closure: Prospective, Randomized Controlled Trial.

Authors:  Anna Serracant; Xavier Serra-Aracil; Laura Mora-López; Anna Pallisera-Lloveras; Sheila Serra-Pla; Alba Zárate-Pinedo; Salvador Navarro-Soto
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

Review 3.  Adiposity and cancer survival: a systematic review and meta-analysis.

Authors:  Elizabeth M Cespedes Feliciano; Bette J Caan; En Cheng; Jocelyn Kirley
Journal:  Cancer Causes Control       Date:  2022-08-15       Impact factor: 2.532

4.  Association of Low Muscle Mass and Low Muscle Radiodensity With Morbidity and Mortality for Colon Cancer Surgery.

Authors:  Jingjie Xiao; Bette J Caan; Elizabeth M Cespedes Feliciano; Jeffrey A Meyerhardt; Peter D Peng; Vickie E Baracos; Valerie S Lee; Sora Ely; Rebecca C Gologorsky; Erin Weltzien; Candyce H Kroenke; Marilyn L Kwan; Stacey E Alexeeff; Adrienne L Castillo; Carla M Prado
Journal:  JAMA Surg       Date:  2020-10-01       Impact factor: 14.766

5.  The association between preoperative body composition and aerobic fitness in patients scheduled for colorectal surgery.

Authors:  Annefleur E M Berkel; Laura van Wijk; David P J van Dijk; Sanne N Prins; Job van der Palen; Nico L U van Meeteren; Steven W M Olde Damink; Joost M Klaase; Bart C Bongers
Journal:  Colorectal Dis       Date:  2021-10-20       Impact factor: 3.917

6.  Low psoas muscle index is a poor prognostic factor for lower gastrointestinal perforation: a single-center retrospective cohort study.

Authors:  Hajime Kayano; Eiji Nomura; Rin Abe; Yasuhiko Ueda; Takashi Machida; Chikara Fujita; Shohei Uchiyama; Kazuyuki Endo; Katsuki Murakami; Masaya Mukai; Hiroyasu Makuuchi
Journal:  BMC Surg       Date:  2019-11-28       Impact factor: 2.102

7.  Is sarcopenia a risk factor for reduced diaphragm function following hepatic resection? A study protocol for a prospective observational study.

Authors:  S W M Olde Damink; Christian S Bruells; Gregory van der Kroft; Sebastian Johannes Johannes Fritsch; S S Rensen; Steffen Wigger; Christian Stoppe; Andreas Lambertz; Ulf Peter Neumann
Journal:  BMJ Open       Date:  2021-11-16       Impact factor: 2.692

8.  Visceral-to-Subcutaneous Fat Ratio Is a Potential Predictor of Postoperative Complications in Colorectal Cancer.

Authors:  An-Qi He; Chun-Qiang Li; Qi Zhang; Tong Liu; Jian Liu; Gang Liu
Journal:  Med Sci Monit       Date:  2021-06-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.